SE

Suad Efendic

EL Eli Lilly: 6 patents #569 of 2,858Top 20%
NA Novo Nordisk A/S: 2 patents #622 of 1,775Top 40%
BA Biocrine Ab: 1 patents #4 of 9Top 45%
GT Governing Council Of The University Of Toronto: 1 patents #286 of 760Top 40%
Overall (All Time): #423,355 of 4,157,543Top 15%
12
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
8206722 Somatostatin receptor antagonists and glucose control or hypoglycemia Mladen Vranic, Jessica Yue 2012-06-26
7862825 Method of controlling tight blood glucose by somatostatin receptor antagonists Mladen Vranic, Jessica Yue 2011-01-04
7381523 Methods for identifying compounds for treating diabetes mellitus 2008-06-03
7211557 Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity Richard D. DiMarchi 2007-05-01
6747006 Use of GLP-1 or analogs in treatment of myocardial infarction 2004-06-08
6583111 Use of GLP-1 analogs and derivative adminstered peripherally in regulation of obesity Richard D. DiMarchi 2003-06-24
6348447 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein Per Hellstrom 2002-02-19
6277819 Use of GLP-1 or analogs in treatment of myocardial infarction 2001-08-21
RE37302 Peptide Mark Gutniak, Ole Kirk 2001-07-31
6191102 Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity Richard D. DiMarchi 2001-02-20
6006753 Use of GLP-1 or analogs to abolish catabolic changes after surgery 1999-12-28
5631224 Use of a peptide Mark Gutniak, Ole Kirk 1997-05-20